122 related articles for article (PubMed ID: 24382482)
1. Polymporphism of monocyte chemoattractant protein 1 (MCP1 -2518 A/G) and responsiveness to hepatitis B vaccination in hemodialysis patients.
Grzegorzewska AE; Pajzderski D; Sowińska A; Jagodziński PP
Pol Arch Med Wewn; 2014; 124(1-2):10-8. PubMed ID: 24382482
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemoattractant protein-1 gene (MCP-1-2518 A/G) polymorphism and serological markers of hepatitis B virus infection in hemodialysis patients.
Grzegorzewska AE; Pajzderski D; Sowińska A; Jagodziński PP
Med Sci Monit; 2014 Jun; 20():1101-16. PubMed ID: 24975639
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi Hemodialysis Center.
Al Saran K; Sabry A; Al Halawany Z; Ismail M
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):185-91. PubMed ID: 24434410
[TBL] [Abstract][Full Text] [Related]
4. Titers of antibodies to the surface antigen of hepatitis B virus after vaccination in relation to immunity-related gene variants. A prospective study among hemodialysis patients.
Jodłowska-Siewert E; Jagodziński PP; Grzegorzewska AE
Pol Arch Intern Med; 2017 Aug; 127(7-8):481-489. PubMed ID: 28817541
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
[TBL] [Abstract][Full Text] [Related]
6. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients.
Grzegorzewska AE; Świderska MK; Mostowska A; Warchoł W; Jagodziński PP
Vaccine; 2016 Sep; 34(41):4866-4874. PubMed ID: 27595449
[TBL] [Abstract][Full Text] [Related]
8. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status.
Ibrahim S; el-Din S; Bazzal I
J Natl Med Assoc; 2006 Dec; 98(12):1953-7. PubMed ID: 17225840
[TBL] [Abstract][Full Text] [Related]
9. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
Kayataş M
Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
Lin SY; Liu JH; Lin CC; Wang SM; Tsai CA; Chou CY; Kuo HL; Wang IK; Liu YL; Lin HH; Huang CC
Vaccine; 2011 May; 29(21):3738-41. PubMed ID: 21458609
[TBL] [Abstract][Full Text] [Related]
11. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population.
Charest AF; Grand'Maison A; McDougall J; Goldstein MB
Am J Kidney Dis; 2003 Dec; 42(6):1193-9. PubMed ID: 14655191
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
13. Relative indoleamine 2,3-dioxygenase transcript level concerning anti-HBs titers in response to HBV vaccination in hemodialysis patients.
Grzegorzewska AE; Frycz BA; Winnicka H; Warchoł W; Jagodziński PP
Expert Rev Vaccines; 2018 Oct; 17(10):947-953. PubMed ID: 30251561
[TBL] [Abstract][Full Text] [Related]
14. Effect of high-flux hemodialysis on delayed hepatitis B virus vaccination response in hemodialysis patients.
He Q; Wu F; Zhang P; Chen J
Postgrad Med; 2011 May; 123(3):150-2. PubMed ID: 21566425
[TBL] [Abstract][Full Text] [Related]
15. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.
Peces R; de la Torre M; Alcázar R; Urra JM
Am J Kidney Dis; 1997 Feb; 29(2):239-45. PubMed ID: 9016896
[TBL] [Abstract][Full Text] [Related]
16. [New vaccination protocol against hepatitis B for hemodialysis patients--a single-centre experience].
Resić H; Kukavica N; Masnić F; Prohić N; Sahović V; Ajanović S; Corić A; Avdić E; Helać-Cvijetić D
Acta Med Croatica; 2011 Dec; 65(5):405-14. PubMed ID: 22994011
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
Charest AF; McDougall J; Goldstein MB
Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
[TBL] [Abstract][Full Text] [Related]
18. Efficient haemodialysis improves the response to hepatitis B virus vaccination.
Kovacic V; Sain M; Vukman V
Intervirology; 2002; 45(3):172-6. PubMed ID: 12403922
[TBL] [Abstract][Full Text] [Related]
19. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
[TBL] [Abstract][Full Text] [Related]
20. IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection.
Grzegorzewska AE; Pajzderski D; Sowińska A; Mostowska A; Jagodziński PP
Vaccine; 2013 Apr; 31(14):1766-70. PubMed ID: 23462527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
